INTRODUCTION: Myxomas are benign tumors of the mesenchymal origin and account for about half of the benign cardiac tumors. Occasionally, they occur at other locations, but the intracranial manifestation of a myxoma is exceptionally rare. As a secondary neoplasia following radiotherapy, myxoma has only been reported once in the literature. MATERIAL AND METHODS: A 12-year-old girl, who was previously treated for a medulloblastoma, was diagnosed with a new lesion at the left transverse sinus in the follow-up magnetic resonance imaging (MRI). Indication for surgery was made and complete removal could be achieved. RESULTS AND DISCUSSION: Histological examination revealed a myxoma. Further staging showed no other manifestation of the myxoma. The close relation to the radiation field of the posterior fossa makes it highly suggestive that the myxoma developed as a secondary neoplasia induced by radiotherapy. Treatment philosophy for this benign tumor entity is a completed resection of the lesion with regular follow-up MRI.
INTRODUCTION:Myxomas are benign tumors of the mesenchymal origin and account for about half of the benign cardiac tumors. Occasionally, they occur at other locations, but the intracranial manifestation of a myxoma is exceptionally rare. As a secondary neoplasia following radiotherapy, myxoma has only been reported once in the literature. MATERIAL AND METHODS: A 12-year-old girl, who was previously treated for a medulloblastoma, was diagnosed with a new lesion at the left transverse sinus in the follow-up magnetic resonance imaging (MRI). Indication for surgery was made and complete removal could be achieved. RESULTS AND DISCUSSION: Histological examination revealed a myxoma. Further staging showed no other manifestation of the myxoma. The close relation to the radiation field of the posterior fossa makes it highly suggestive that the myxoma developed as a secondary neoplasia induced by radiotherapy. Treatment philosophy for this benign tumor entity is a completed resection of the lesion with regular follow-up MRI.
Authors: U Sure; H Bertalanffy; S Isenmann; S Brandner; W J Berghorn; W Seeger; A Aguzzi Journal: Acta Neurochir (Wien) Date: 1995 Impact factor: 2.216
Authors: Bryan G Wachter; Mark J Steinberg; David H Darrow; Jonathan D McGinn; Albert H Park Journal: Int J Pediatr Otorhinolaryngol Date: 2003-04 Impact factor: 1.675
Authors: M Nagatani; S Mori; N Takimoto; N Arita; Y Ushio; T Hayakawa; M Gen; T Uozumi; H Mogami Journal: Neurosurgery Date: 1987-02 Impact factor: 4.654
Authors: A V Moiyadi; A A Moiyadi; S Sampath; S R Kalpana; A Mahadevan; S K Shankar; S G Srikanth Journal: Acta Neurochir (Wien) Date: 2007-10-01 Impact factor: 2.216